| ［1］ Prevarskaya N, Skryma R, Shuba Y. Targeting Ca2+ transport in cancer: close reality or long perspective?［J］. Expert Opin Ther Targets, 2013, 17(3): 225-241.
［2］ Taylor JT, Zeng XB, Pottle JE, et al. Calcium signaling and Ttype calcium channels in cancer cell cycling［J］. World J Gastroenterol, 2008, 14(32): 4984-4991.
［3］ Lu F, Chen H, Zhou C, et al. Ttype Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation［J］. Cell Calcium, 2008, 43(1): 4958.
［4］ Ohkubo T, Yamazaki J. Ttype voltageactivated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF7 human breast cancer cells［J］. Int J Oncol, 2012, 41(1): 267-275.
［5］ Li W, Zhang SL, Wang N, et al. Blockade of Ttype Ca2+ channels inhibits human ovarian cancer cell proliferation［J］. Cancer Invest, 2011, 29(5): 339-346.
［6］ Zhang Y, Zhang J, Jiang D, et al. Inhibition of Ttype Ca2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration［J］. Br J Pharmacol, 2012, 166(4): 1247-1260.
［7］ Valerie NC, Dziegielewska B, Hosing AS, et al. Inhibition of Ttype calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells［J］. Biochem Pharmacol, 2013, 85(7): 888-897.
［8］ Sheehan JP, Xu Z, Popp B, et al. Inhibition of glioblastoma and enhancement of survival via the use of mibefradil in conjunction with radiosurgery［J］. J Neurosurg, 2013, 118(4): 830-837.
［9］ Keir ST, Friedman HS, Reardon DA, et al. Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model［J］. J Neurooncol, 2013, 111(2): 97-102.
［10］ Santoni G, Farfariello V. TRP channels and cancer: new targets for diagnosis and chemotherapy［J］. Endocr Metab Immune Disord Drug Targets, 2011, 11(1): 54-67.
［11］ Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer［J］. Biochim Biophys Acta, 2007, 1772(8): 937-946.
［12］ Gkika D, Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis［J］. Biochim Biophys Acta, 2009, 1793(6): 953-958.
［13］ Santoni G, Farfariello V, Amantini C. TRPV channels in tumor growth and progression［J］. Adv Exp Med Biol, 2011, 704: 947-967.
［14］ Bomben VC, Sontheimer HW. Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas［J］. Cell Prolif, 2008, 41(1): 98-121.
［15］ Bomben VC, Sontheimer H. Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas［J］. Glia, 2010, 58(10): 1145-1156.
［16］ Malarkey EB, Ni Y, Parpura V. Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes［J］. Glia, 2008, 56(8): 821-835.
［17］ Ding X, He Z, Zhou K, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma［J］. J Natl Cancer Inst, 2010, 102(14): 1052-1068.
［18］ Chigurupati S, Venkataraman R, Barrera D, et al. Receptor channel TRPC6 is a key mediator of Notchdriven glioblastoma growth and invasiveness［J］. Cancer Res, 2010, 70(1): 418-427.
［19］ Amantini C, Mosca M, Nabissi M, et al. Capsaicininduced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation［J］. J Neurochem, 2007, 102(3): 977-990.
［20］ Stock K, Kumar J, Synowitz M, et al. Neural precursor cells induce cell death of highgrade astrocytomas through stimulation of TRPV1［J］. Nat Med, 2012, 18(8): 1232-1238.
［21］ Nabissi M, Morelli MB, Amantini C, et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fasinduced apoptosis in ERKdependent manner［J］. Carcinogenesis, 2010, 31(5): 794-803.
［22］ Nabissi M, Morelli MB, Santoni M, et al. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents［J］. Carcinogenesis, 2013, 34(1): 48-57. |
